Literature DB >> 23355743

Clinical evidence for the role of Trichomonas vaginalis in regulation of secretory leukocyte protease inhibitor in the female genital tract.

Jill S Huppert1, Bin Huang, Chen Chen, Hassan Y Dawood, Raina N Fichorova.   

Abstract

BACKGROUND: Secretory leukocyte protease inhibitor (SLPI) is responsible for regulating inflammatory damage to and innate and adaptive immune responses in the vaginal mucosa. Depressed cervicovaginal SLPI levels have been correlated with both Trichomonas vaginalis infection and poor reproductive health outcomes.
METHODS: We measured levels of SLPI in 215 vaginal specimens collected from adolescent and young adult females aged 14-22 years. Log-transformed SLPI values were compared by analysis of variance or by an unpaired t test before and after adjustment for confounding effects through the propensity score method.
RESULTS: Females receiving hormonal contraceptives and those with an abnormal vaginal pH had lower SLPI levels as compared to their peers. After propensity score adjustment for race, behavioral factors, hormonal use, and other sexually transmitted infections (STIs), SLPI levels were lower in females with a positive T. vaginalis antigen test result, a vaginal pH >4.5, vaginal leukocytosis, and recurrent (vs initial) T. vaginalis infection, with the lowest levels observed in those with the highest T. vaginalis loads.
CONCLUSIONS: The SLPI level was reduced by >50% in a T. vaginalis load-dependent manner. Future research should consider whether identifying and treating females with low levels of T. vaginalis infection (before they become wet mount positive) would prevent the loss of SLPI and impaired vaginal immunity. The SLPI level could be used as a vaginal-health marker to evaluate interventions and vaginal products.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23355743      PMCID: PMC3610423          DOI: 10.1093/infdis/jit039

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  49 in total

1.  Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection.

Authors:  M A Klebanoff; J C Carey; J C Hauth; S L Hillier; R P Nugent; E A Thom; J M Ernest; R P Heine; R J Wapner; W Trout; A Moawad; K J Leveno; M Miodovnik; B M Sibai; J P Van Dorsten; M P Dombrowski; M J O'Sullivan; M Varner; O Langer; D McNellis; J M Roberts
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

2.  The laboratory diagnosis of Trichomonas vaginalis.

Authors:  Gary E Garber
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-01       Impact factor: 2.471

3.  Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis.

Authors:  J R Schwebke; S L Hillier; J D Sobel; J A McGregor; R L Sweet
Journal:  Obstet Gynecol       Date:  1996-10       Impact factor: 7.661

4.  Adolescent women can perform a point-of-care test for trichomoniasis as accurately as clinicians.

Authors:  Jill S Huppert; Elizabeth Hesse; Grace Kim; Michael Kim; Patricia Agreda; Nicole Quinn; Charlotte Gaydos
Journal:  Sex Transm Infect       Date:  2010-06-30       Impact factor: 3.519

5.  The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission.

Authors:  R N Fichorova; L D Tucker; D J Anderson
Journal:  J Infect Dis       Date:  2001-07-16       Impact factor: 5.226

6.  A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis.

Authors:  W Wiese; S R Patel; S C Patel; C A Ohl; C A Estrada
Journal:  Am J Med       Date:  2000-03       Impact factor: 4.965

7.  Vaginal polymorphonuclear leukocytes and bacterial vaginosis as markers for histologic endometritis among women without symptoms of pelvic inflammatory disease.

Authors:  Mark H Yudin; Sharon L Hillier; Harold C Wiesenfeld; Marijane A Krohn; Antonio A Amortegui; Richard L Sweet
Journal:  Am J Obstet Gynecol       Date:  2003-02       Impact factor: 8.661

8.  Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis.

Authors:  Karen A Wendel; Emily J Erbelding; Charlotte A Gaydos; Anne M Rompalo
Journal:  Clin Infect Dis       Date:  2002-08-06       Impact factor: 9.079

9.  Bacterial vaginosis in sexually experienced and non-sexually experienced young women entering the military.

Authors:  Sophia Yen; Mary-Ann Shafer; Jeanne Moncada; Christopher J Campbell; Scott D Flinn; Cherrie B Boyer
Journal:  Obstet Gynecol       Date:  2003-11       Impact factor: 7.661

10.  Real-time PCR improves detection of Trichomonas vaginalis infection compared with culture using self-collected vaginal swabs.

Authors:  A M Caliendo; J A Jordan; A M Green; J Ingersoll; R J Diclemente; G M Wingood
Journal:  Infect Dis Obstet Gynecol       Date:  2005-09
View more
  9 in total

Review 1.  Putative functions of tissue kallikrein-related peptidases in vaginal fluid.

Authors:  Carla M J Muytjens; Stella K Vasiliou; Katerina Oikonomopoulou; Ioannis Prassas; Eleftherios P Diamandis
Journal:  Nat Rev Urol       Date:  2016-09-07       Impact factor: 14.432

Review 2.  The Human Microbiome during Bacterial Vaginosis.

Authors:  Andrew B Onderdonk; Mary L Delaney; Raina N Fichorova
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

3.  Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.

Authors:  Jordan K Kyongo; Tania Crucitti; Joris Menten; Liselotte Hardy; Piet Cools; Johan Michiels; Sinead Delany-Moretlwe; Mary Mwaura; Gilles Ndayisaba; Sarah Joseph; Raina Fichorova; Janneke van de Wijgert; Guido Vanham; Kevin K Ariën; Vicky Jespers
Journal:  Clin Vaccine Immunol       Date:  2015-03-11

4.  The villain team-up or how Trichomonas vaginalis and bacterial vaginosis alter innate immunity in concert.

Authors:  Raina N Fichorova; Olivia R Buck; Hidemi S Yamamoto; Titilayo Fashemi; Hassan Y Dawood; Bisiayo Fashemi; Gary R Hayes; David H Beach; Yuko Takagi; Mary L Delaney; Max L Nibert; Bibhuti N Singh; Andrew B Onderdonk
Journal:  Sex Transm Infect       Date:  2013-07-31       Impact factor: 3.519

Review 5.  Biological roles of cysteine proteinases in the pathogenesis of Trichomonas vaginalis.

Authors:  Hilda M Hernández; Ricardo Marcet; Jorge Sarracent
Journal:  Parasite       Date:  2014-10-28       Impact factor: 3.000

Review 6.  Trichomoniasis immunity and the involvement of the purinergic signaling.

Authors:  Camila Braz Menezes; Tiana Tasca
Journal:  Biomed J       Date:  2016-09-21       Impact factor: 4.910

Review 7.  Immunopathology of Recurrent Vulvovaginal Infections: New Aspects and Research Directions.

Authors:  Namarta Kalia; Jatinder Singh; Manpreet Kaur
Journal:  Front Immunol       Date:  2019-08-28       Impact factor: 7.561

8.  The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.

Authors:  Raina N Fichorova; Pai-Lien Chen; Charles S Morrison; Gustavo F Doncel; Kevin Mendonca; Cynthia Kwok; Tsungai Chipato; Robert Salata; Christine Mauck
Journal:  MBio       Date:  2015-09-01       Impact factor: 7.867

9.  Trichomonas vaginalis Lipophosphoglycan Exploits Binding to Galectin-1 and -3 to Modulate Epithelial Immunity.

Authors:  Raina N Fichorova; Hidemi S Yamamoto; Titilayo Fashemi; Evan Foley; Stanthia Ryan; Noah Beatty; Hassan Dawood; Gary R Hayes; Guillaume St-Pierre; Sachiko Sato; Bibhuti N Singh
Journal:  J Biol Chem       Date:  2015-11-20       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.